The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism
Open accessAbstract
Significance: The absence of appropriate transgenic animal models of renal cell carcinomas (RCCs) has made it difficult to identify and test new therapies for this disease. We developed a new transgenic mouse model of a highly aggressive form of RCC in which tumor growth and regression is conditionally regulated by the MYC oncogene. Using desorption electrospray ionization–mass-spectrometric imaging, we found that certain glycerophosphoglycerols and metabolites of the glutaminolytic pathway were higher in abundance in RCC than in normal kidney tissue. Up-regulation of glutaminolytic genes and proteins was identified by genetic analysis and immunohistochemistry, therefore suggesting that RCC tumors are glutamine addicted. Pharmacological inhibition of glutaminase slowed tumor progression in vivo, which may represent a novel therapeutic route for RCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, the specific metabolic importance of glutamine in tumorigenesis and tumor growth has also been reported194–196”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [196]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,432
Brocken, P., van der Heijden, E. H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus‐Oei, L. (2013) · Respiration · doi:10.1159/000347096 · Cited by 4,011
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Self-citationWise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,722
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Cited by
Sorted by citations
Items 201–256 of 256
Signatures of Co-Deregulated Genes and Their Transcriptional Regulators in Kidney Cancers
Ioannou, I., Chatziantoniou, A., Drenios, C., Christodoulou, P., Kourti, M., & Zaravinos, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076577 · Cited by 6
Liu, L., Zhang, S., Yang, H., Zhou, C., Xiong, Y., Yang, N., & Tian, Y. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-023-01960-7 · Cited by 6
Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies
Gothland, A., Jary, A., Grange, P., Leducq, V., Remigereau, L. B., Dupin, N., Marcelin, A., & Cálvez, V. (2022) · Antioxidants · doi:10.3390/antiox12010084 · Cited by 6
Sapkota, D., Wang, D., Schreurs, O., Vallenari, E. M., Dhakal, S., Küntziger, T. M., Şengüven, B., Utheim, T. P., & Chaudhry, F. A. (2024) · Cancers · doi:10.3390/cancers16020405 · Cited by 5
Yao, Z., Zheng, Z., Zheng, X., Wu, H., Zhao, W., Mu, X., Sun, F., Wu, K., & Zheng, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9039732 · Cited by 5
Zhao, H., Wu, Y., & Kim, S. M. (2025) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.24.274 · Cited by 4
Beyond the Limit: MYC Mediates Tumor Immune Escape
Hong, Z., Ming, S., Luan, X., Sun, Z., & Zhang, W. (2025) · Pharmaceuticals · doi:10.3390/ph18070978 · Cited by 4
Song, W., Zhang, H., Ni, J., Hu, H., Mao, W., Wang, K., & Peng, B. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113776 · Cited by 4
Fueling the fire–a pan-cancer analysis of MYC-regulated lipid metabolism
Chatterjee, T., Beffert, E., & Liefwalker, D. F. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1669544 · Cited by 4
Imaging mammalian lipids using desorption electrospray ionization mass spectrometry: A review
Ghoush, R. A., Geday, F., Alon, O., Vijayalakshmi, K., Noll, S. E., & Margulis, K. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345143 · Cited by 4
Cancer Biology and the Principles of Targeted Cancer Drug Discovery
Hillmann, P., Schmitz, D., Mestan, J., D'Allonzo, S., & Fabbro, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12390-x · Cited by 4
Computational Identification of Master Regulators Influencing Trypanotolerance in Cattle
Rajavel, A., Schmitt, A. O., & Gültaş, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020562 · Cited by 4
Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors
Hylton-McComas, H. M., Cordes, A. F., Floros, K. V., Faber, A. C., Drapkin, B. J., & Miles, W. O. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189332 · Cited by 3
Li, Z., Deng, J., Wang, H., Liu, T., Zhou, Y., Ouyang, P., Liang, X., Zhang, X., Qi, S., & Li, Y. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101834 · Cited by 3
Self-citationZou, C., Wang, Y. J., Chen, Q., Shi, J., Wu, X., & Luo, Q. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1745024 · Cited by 3
Spatial Metabolomics Using Imaging Mass Spectrometry
Vijayalakshmi, K. (2023) · Springer eBooks · doi:10.1007/978-3-031-39094-4_13 · Cited by 3
Metabolic Reprogramming and Molecular Rewiring in Cancer: Therapeutic Opportunities
Meiliana, A., Dewi, N. M., & Wijaya, A. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i2.1598 · Cited by 3
Khochare, S., Li, X., Yang, X., Shi, Y., Feng, G., Ruchhoeft, P., Shih, W., & Shan, X. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04301 · Cited by 3
Desorption Electrospray Ionization Mass Spectrometry Imaging for Tissue Analysis
Song, X., & Chen, H. (2020) · Wiley eBooks · doi:10.1002/9780470027318.a9640 · Cited by 3
The Interplay of Splicing and Metabolism in Cancer
Voss, D. M., Cui, Y., & Klein, P. S. (2026) · Cells · doi:10.3390/cells15121117 · Cited by 3
Gouw, A. M., Kumar, V., Resendez, A., Alvina, F. B., Liu, N. S., Margulis, K., Tong, L., Zare, R. N., Malhotra, S. V., & Felsher, D. W. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00673 · Cited by 2
Self-citationProfiling Kinase Activities for Precision Oncology in Diffuse Gastric Cancer
Singh, S., Parthasarathi, K. T. S., Bhat, M. Y., Gopal, C., Sharma, J. N., & Pandey, A. (2024) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2023.0173 · Cited by 2
Resistance mechanisms in anaplastic lymphoma kinase-positive lung cancer
Behinaein, P., Gadgeel, S. M., Rattan, R., MacKeigan, J. P., Pilling, A. B., Rous, F. A., Martin, K. R., & Okereke, I. C. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104821 · Cited by 2
Acinar-to-ductal metaplasia in the pancreas requires a glycolytic switch and functional mitochondriaPreprint
Neuß, T., Wirges, N., Chen, M., Usluer, S., Oellinger, R., Lier, S., Dudek, M., Madl, T., Jastroch, M., Steiger, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.495427 · Cited by 2
Targeting USP28 inhibits clear cell renal cell carcinoma growth
Ren, Y., Yang, Y., Zhu, X., Li, L., Pan, Y., Sun, H., Fang, Q., Xiong, H., Guo, D., Sun, Y., et al. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112344 · Cited by 1
A panel of three serum microRNAs as a potential diagnostic biomarker for renal cell carcinoma
Lin, S., Li, X., Ge, Z., Chen, W., Li, Y., Zhang, P., Wu, Y., Wang, W., Chen, S., Zhou, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-01225-6 · Cited by 1
Self-citationTargeting the Glutaminolysis Pathway in Glaucoma-Associated Fibrosis
Kelly, Á., Irnaten, M., & O’Brien, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010012 · Cited by 1
Advanced drug delivery systems in kidney cancer
Nimisha, Singh, A., & Pandey, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85503-7.00018-3 · Cited by 1
Translating L-2-HG to kidney cancer at the bench and bedside
Aboud, O. A., & Weiss, R. H. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.11.41 · Cited by 1
Disease Tissue Imaging and Single Cell Analysis with Mass Spectrometry
Hamilton, J. S. (2017) · University of North Texas Digital Library (University of North Texas) · doi:10.12794/metadc984137
Mitochondria Remodeling in Cancer
Dornfeld, K. J., & Skildum, A. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_9
Tumorigenesis and Metabolism Disorder
Yang, F., Shu, L., & Zhang, X. (2019) · Springer eBooks · doi:10.1007/978-981-13-6198-2_7
SETD2 deficiency impairs β-catenin destruction complex to facilitate renal cell carcinoma formationPreprint
Rao, H., Li, X., Liu, M., Liu, J., Feng, W., Xu, J., Gao, W., & Li, L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.13.200220
Barakzai, M. A., Akhtar, M., Afsar, N. A., Alsalloom, A. A. M., Kashir, J., & Hussain, T. O. A. (2020) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2020.08.857
The involvement of mitochondrial proteins in tumorigenesis
Li, M. (2021) · Frontiers in Medical Science Research · doi:10.25236/fmsr.2021.030502
Wang, M., Guo, H., Gu, H., & Zhang, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.31.478529
Rajavel, A. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9595
Introduction to Tumor Ecosystem
Saw, P. E., & Song, E. (2023) · Springer eBooks · doi:10.1007/978-981-99-1183-7_1
Linscott, M. P., Ren, J. R., Gestl, S. A., & Gunther, E. J. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.02.018
Metabolic Reprogramming of Clear Cell Renal Cell Carcinoma and Its Clinical Significance
周, 文. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1451486
The glutamine-aspartate metabolic tradeoff between fast growth and metabolic flexibility
Ortmayr, K., Ringwald, M., Schuhknecht, L., Dubuis, S., Paunossis, E., Blaesi, M., Jehanno, C., Grieder, S. D., Bentires‐Alj, M., Mall, M., et al. (2026) · Genome biology · doi:10.1101/2025.05.12.652188
Amato, R., Banella, C., Subbiani, A., Pasha, A., Mattei, G., Carrozzo, F., Ascone, M., Lotti, M., Lorito, N., Favre, C., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6448362/v1
Liu, Y., He, J., Lyu, D., Yang, X., Zhang, H., Tu, S., Yao, Y., Wei, M., Li, Y., Zhao, Z., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1537805
Self-citationAntitumor Activity of Alexidine Dihydrochloride Nanocarriers in Renal Cell Carcinoma
Sultan, A., Zoabi, A., Morshin, A., Shalev, O., Lazarovici, P., & Margulis, K. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c00651
Liu, L., Zhang, S., Yang, H., Zhou, C., Xiong, Y., Yang, N., & Tian, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24995537
Liefwalker, D. F., Ryan, M., Wang, Z., Pathak, K. V., Plaisier, S. B., Shah, V., Babra, B., Dewson, G. S., Lai, I. K., Mosley, A. R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15179621
Self-citationHereditary cancer syndromes linked to oxidative phosphorylation insufficiency
Kaplan, B., Duraj, T., Lee, D. C., & Seyfried, T. N. (2025) · ONCOLOGIE · doi:10.1515/oncologie-2025-0301
Biochemical characterization of mTORC1 regulation by glutamine metabolism
Bodineau, C. (2020) · theses.fr (ABES) · doi:10.70675/9d5aaabdz81bdz4118zb3edze237bdd8dee0
Hétérogénéité métabolique des gliomes : apport de la spectroscopie RMN HRMAS
Bund, C. (2020) · theses.fr (ABES) · doi:10.70675/2f880f7az9a01z463fz9f4az0dcaad5fcf59
Maloberti, T., Nannini, M., Astolfi, A., Nigro, M. C., Gozzellino, L., Costa, A., Pirini, M. G., Leo, A. D., Grillini, M., Vincenzi, B., et al. (2026) · Laboratory Investigation · doi:10.1016/j.labinv.2026.106148
From Tissue Specificity to Systemic Cues: Shaping MYC-Driven Tumor Metabolism
Alamoudi, A. A., Mao, Y., Zadra, G., & Labbé, D. P. (2026) · Cancer Research · doi:10.1158/0008-5472.can-26-0142
Malaria and cancer: common features and interactions
Su, X., Stadler, R. V., Teklemichael, A. A., Xu, F., & Wu, J. (2026) · Trends in Parasitology · doi:10.1016/j.pt.2026.07.004
Feifan, T., Liao, S., Hou, X., & Zhang, B. (2026) · Research Square · doi:10.21203/rs.3.rs-10277358/v1
Macrophage-supported metabolic adaptation drives tumor survival under nutrient stress
Santiappillai, N. T., Cho, A., Verch, G., Codo, A. C., Nair, A., Wang, Y.-T., Lipshutz, A. B., de la Torre, C. M., Liu, E. M., Berishaj, M., et al. (2026) · Science Advances · doi:10.1126/sciadv.aei2831
Glutamine Metabolism in Health and Diseases
Ding, Y., Tong, F., Zeng, J., & Cui, C. (2026) · MedComm · doi:10.1002/mco2.71035
Metadata
- Authors
- Shroff, E. H., Eberlin, L. S., Dang, V. M., Gouw, A. M., Gabay, M., Adam, S. J., Bellovin, D. I., Tran, P. T., Philbrick, W. M., Garcia-Ocana, A., Casey, S. C., Li, Y., Dang, C. V., Zare, R. N., & Felsher, D. W.
- Affiliations
- Division of Medical Oncology, Departments of Medicine and Pathology, and
- Department of Chemistry, Stanford University School of Medicine, Stanford, CA 94305;
- Abramson Cancer Center (US)
- Johns Hopkins University (US)
- Yale University (US)
- Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029
- Stanford Medicine (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-05-11
- Volume
- 112
- Issue
- 21
- Pages
- 6539-6544
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4450371
- OpenAlex
- W1772301402
- Cited by
- 255
- References
- 64
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 23 · 2023: 22 · 2022: 34 · 2021: 24 · 2020: 29 · 2019: 18 · 2018: 22 · 2017: 26 · 2016: 20 · 2015: 4
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | National Institutes of Health (CA 089305, 105102, 170378)
- HHS | NIH | National Cancer Institute (CA 114747, CA 112973, U01 CA188383, CA034233, CA 184384)
- Leukemia and Lymphoma Society (R6223-07)
- American Lung Association (RT-169741-N)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- MYC oncogene, renal cell carcinoma, glutamine metabolism, glutaminolysis, oncogenic Ras, tumor progression, cancer metabolism, desorption electrospray ionization mass spectrometry imaging
- MeSH terms
- Animals, Carcinoma, Renal Cell, Disease Models, Animal, Enzyme Inhibitors, Glutaminase, Glutamine, Humans, Kidney Neoplasms, Mice, Transgenic, Genes, ras, RNA, Messenger, RNA, Neoplasm, Sulfides, Thiadiazoles, Up-Regulation, Genes, myc, Mice, SCID, Disease Progression, Spectrometry, Mass, Electrospray Ionization, Cell Line, Tumor, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
